OTCPK:SKTO

Stock Analysis Report

Executive Summary

SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • SK3 Group has significant price volatility in the past 3 months.
  • SK3 Group's last earnings update was 3068 days ago.
  • SK3 Group is not covered by any analysts.

Share Price & News

How has SK3 Group's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:SKTO

0.8%

US Healthcare

1.3%

US Market


1 Year Return

0%

OTCPK:SKTO

-8.2%

US Healthcare

2.0%

US Market

SKTO outperformed the Healthcare industry which returned -8.2% over the past year.

SKTO underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

SKTOIndustryMarket
7 Day0%0.8%1.3%
30 Day-99.0%-1.5%3.9%
90 Day-99.0%-0.5%3.4%
1 Year0%0%-6.8%-8.2%4.2%2.0%
3 Year-99.0%-99.0%30.2%24.9%47.2%37.6%
5 Year-99.9%-99.9%63.6%53.9%60.5%42.9%

Price Volatility Vs. Market

How volatile is SK3 Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is SK3 Group undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether SK3 Group is trading at an attractive price based on the cash flow it is expected to produce in the future. But as SK3 Group has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine SK3 Group's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through SK3 Group regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is SK3 Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SK3 Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has SK3 Group performed over the past 5 years?

0.1%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, SK3 Group has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is SK3 Group's financial position?


In this section we usually analyse SK3 Group's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. SK3 Group has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of SKTO’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when SK3 Group's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is SK3 Group's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate SK3 Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate SK3 Group's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as SK3 Group has not reported any payouts.

Unable to verify if SK3 Group's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as SK3 Group has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of SK3 Group's salary, the management and board of directors tenure and is there insider trading?


CEO

Artemus Mayor (51yo)

0yrs

Tenure

0

Mr. Artemus Mayor serves as Chief Executive Officer and President of SK3 Group Inc. Mr. Mayor served as Vice President of Sales at Healthcare Of Today, Inc. since May 2008. From 2004 to 2007, Mr. Mayor ser ...


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Artemus Mayor (51yo)

    Chief Executive Officer and President

    • Tenure: 0yrs

Board Members

  • Kevin Allyn

    Chairman

    • Tenure: 6.5yrs
  • David Hoye

    Director

    • Tenure: 5.4yrs

Company Information

SK3 Group, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: SK3 Group, Inc.
  • Ticker: SKTO
  • Exchange: OTCPK
  • Founded: 2000
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$827.000
  • Shares outstanding: 827.94m
  • Website: https://null

Number of Employees


Location

  • SK3 Group, Inc.
  • 448 South Hill Street
  • Suite 405
  • Los Angeles
  • California
  • 90013
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SKTOOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2007

Biography

SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/15 00:23
End of Day Share Price2019/09/13 00:00
Earnings2010/12/31
Annual Earnings2010/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.